Stay updated on Risdiplam in SMA Infants Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Infants Clinical Trial page.

Latest updates to the Risdiplam in SMA Infants Clinical Trial page
- Check2 days agoChange DetectedTwo U.S. NIH grant/contract references, dated 2018 and 2023, were removed from the record. The site revision changed from v3.8.0 to v3.8.1.SummaryDifference0.2%

- Check9 days agoChange DetectedThe clinical trial record for the RAINBOWFISH study is displayed, with details about risdiplam treatment, study design, participant eligibility, and measured outcomes.SummaryDifference59%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference1%

- Check37 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.0.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, indicating access is blocked; the rendered page includes the site's header and footer with the 403 message.SummaryDifference19%

Stay in the know with updates to Risdiplam in SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Infants Clinical Trial page.